Home » Topics » BioWorld Science

BioWorld Science
RSS

Albireo presents new SLC10A2 and/or SLC10A1 inhibitors

Aug. 27, 2020

TLR adjuvant makes for longer immune responses

Aug. 27, 2020

Expression Therapeutics developing gene therapy candidate for FHL3

Aug. 27, 2020

BBT-032 inhibits growth of the SARS-CoV-2 virus in preclinical studies

Aug. 27, 2020

Interim results from a phase I trial of FixVac RNA vaccine in patients with advanced melanoma

Aug. 27, 2020

How antidepressants inhibit fibrosis

Aug. 27, 2020

Cross-reactive immunity helps antitumor response

Aug. 27, 2020

Phase III ASCEMBL study of asciminib in CML meets primary endpoint

Aug. 26, 2020

Mereo BioPharma initiates phase Ib/II study of alvelestat in COVID-19 respiratory disease

Aug. 26, 2020

Positive topline data from phase IIa trial of IMVT-1401 in myasthenia gravis

Aug. 26, 2020

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...